Physician profile
John Rice
NPI 1821079492
$1,583.29
in general payments reported to CMS, 2019-2025
23 companies · $96.58 in 2025
The $96.58 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $920 · 2020: $297 · 2021: $121 · 2022: $132 · 2023: $15.31 · 2025: $96.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $111.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $306.49 | 2019-2020 | |
| Lilly USA, LLC | $246.84 | 2019-2025 | Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $183.22 | 2019-2025 | Arexvy, Shingrix |
| Sanofi-Aventis U.S. LLC | $111.72 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.80 | 2019-2021 | |
| Medtronic, INC. | $103.93 | 2022 | |
| Tris Pharma INC | $70.83 | 2019-2020 | |
| Abbvie INC. | $57.24 | 2021-2023 | |
| Grifols USA, LLC | $49.62 | 2019-2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $46.78 | 2020-2025 | Gardasil 9, Capvaxive |
| Kowa Pharmaceuticals America, INC. | $42.62 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $34.90 | 2019-2020 | |
| Celgene Corporation | $32.76 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.43 | 2019-2020 | |
| Sandoz INC. | $27.69 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $23.86 | 2019 | |
| Genentech USA, INC. | $18.83 | 2020 | |
| Allergan, INC. | $17.86 | 2019 | |
| Ironshore Pharmaceuticals INC. | $16.60 | 2020 | |
| Amarin Pharma, INC. | $14.95 | 2020 | |
| Exact Sciences Corporation | $14.20 | 2025 | The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $14.02 | 2025 | Wegovy |
| Medtronic Minimed, INC. | $12.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.